About the webinar
Employers and plans are anxious to curb the rising cost of new GLP-1 medications for obesity without cutting off access completely. Partnerships between PBMs and obesity solutions are critical to building an effective obesity strategy.
Richard Frank, Chief Medical Officer at Vida Health, and Sara Izadi, Chief Clinical Officer at Capital Rx, discuss effective GLP-1 utilization management strategies for diverse populations.
Watch the replay to learn:
- How employers and health plans benefit when PBMs partner with obesity solutions
- More about the advantages and challenges of prior authorization
- How the member experience improves when obesity care integrates with their pharmacy benefits
Featured speakers
Dr. Richard Frank
Chief Medical Officer
at Vida
Sara Izadi, PharmD
Chief Clinical Officer at Capital Rx
Dominic Belmonte
Senior Manager of Partnerships at Vida
Want to learn more?
Vida’s holistic care model and relationships with major PBMs allow us to support high-value coverage strategies in ways others can’t. Want to see how one company reduced its GLP-1 impact with Vida?